United States· US:23155-233_05cb7bca-c16a-48b3-9946-18eba53d16db
glyburide-metformin hydrochloride
A medicinal product containing glyburide; metformin hydrochloride, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GLYBURIDE; METFORMIN HYDROCHLORIDE
- Manufacturer
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- July 12, 2026
Packs & prices · 3
- ndc1123155-233-01
- ndc1123155-233-05
- ndc1123155-233-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb73f4f5-cb90-4fe6-8bd4-0a331e4782de GET /v1/drugs/cb73f4f5-cb90-4fe6-8bd4-0a331e4782de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "1.25; 250",
"substance": "GLYBURIDE; METFORMIN HYDROCHLORIDE",
"productndc": "23155-233",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "ANDA079009",
"marketing_category": "ANDA"
}See everything about glyburide; metformin hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.